Initial Evaluation of the Utility of Ferumoxytol for MR Runoffs

We describe the first use of Ferumoxytol as an MR contrast agent for use in MR runoffs. In order to minimize T2* effects, the agent must be diluted during the dynamic arterial phases. When diluted, ferumoxytol performs well as an alternative contrast agent in patients with renal disease.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.